RN624 For Pain Of Post-Herpetic Neuralgia

PHASE2CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

December 19, 2007

Primary Completion Date

December 20, 2008

Study Completion Date

January 7, 2009

Conditions
Neuralgia, Postherpetic
Interventions
DRUG

RN624

50 mcg/kg

DRUG

RN624

200 mcg/kg

DRUG

Placebo

placebo

Trial Locations (31)

16602

Allegheny Pain Management, PC, Altoona

21286

International Research Center, Towson

23294

National Clinical Research, Incorporated, Richmond

28806

Asheville Neurology Specialists, PA, Asheville

33175

Miami Medical Associates, Miami

33351

Neurology Clinical Research, Inc., Sunrise

33418

Palm Beach Neurological Center, Advanced Research Consultants, Inc., Palm Beach Gardens

33462

Jem Research, LLC, Atlantis

33606

Meridien Research, Tampa

33765

Clinical Research of West Florida, Clearwater

33770

Innovative Research of West Florida, Inc., Largo

36207

Anniston Medical Clinic/Pinnacle Research Group LLC, Anniston

Anniston Neurology & Headache Mgmt. Ctr., Anniston

44122

Rapid Medical Research, Inc., Cleveland

45429

Wells Institute for Health Awareness, Kettering

45432

Hometown Urgent Care and Research, Dayton

48104

Michigan Head Pain and Neurological Institute, Ann Arbor

55435

Medical Advanced Pain Specialists (MAPS), Edina

63141

A & A Pain Institute, St Louis

66606

Cotton-O'Neil Clinical Research, Topeka

Cotton-O'Neil Clinic, Topeka

75230

Neurological Clinic of Texas, Dallas

77024

Mobley Research Center, Houston

77802

DiscoveResearch Incorporated, Bryan

78229

Clinical Trials of Texas, Inc., San Antonio

Jay Ellis Jr., MD-Tejas Anesthesia, San Antonio

Radiant Research San Antonio Northeast, San Antonio

85023

Arizona Research Center, Phoenix

85340

Dedicated Clinical Research, Inc., Litchfield Park

02747

Infinity Medical Research, Inc., North Dartmouth

16635-0909

Altoona Center for Clinical Research, Duncansville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY